A Black Eye, Drug Allegations, and Political Whirlwinds
Elon Musk's Odd Exit from Trump's Administration Unravels Drama
Elon Musk, previously Trump's 'cost‑cutter‑in‑chief,' bids an unusual farewell to the administration with a mysterious black eye and a vehement denial of drug allegations. Amidst accolades from Trump, questions about Musk's initiatives continue to swirl.
Elon Musk's Role in the Trump Administration
Drug Allegations and Musk's Denial
Controversial Farewell in the Oval Office
Financial Impact of Musk's DOGE
Reason Behind Musk's Departure
Public and Political Reactions
Musk's Black Eye: Explanation and Speculation
Future of DOGE and Political Implications
Social and Economic Consequences
Expert Opinions and Media Coverage
Related News
Apr 29, 2026
Elon Musk Seeks Sam Altman's Removal in High-Stakes OpenAI Court Battle
Elon Musk takes OpenAI's Sam Altman to court, alleging Altman veered OpenAI away from its nonprofit roots. Musk claims theft, aiming to restore the company's original mission. With OpenAI now valued at $852 billion, Musk's legal fight spotlights massive stakes.
Apr 24, 2026
Tesla's $25B Bet on AI and Robotics: Big Risks, Bigger Dreams
Tesla's Q1 2026 doubled expectations but the buzz is all about their $25B CapEx plan. Elon Musk is going full tilt on robotics and AI, repositioning Tesla beyond cars. Can this audacious pivot pay off?
Apr 24, 2026
Tesla Buys NeuralPath AI for $450M to Boost Self-Driving Tech
Tesla acquires NeuralPath AI for $450M, aiming to enhance its Full Self-Driving capabilities. The acquisition adds 50 engineers to Tesla's Austin team and promises firmware updates by Q3 2026.